These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4068009)

  • 1. Acetoxy-substituted 1,1,2-triphenylbut-1-enes with antiestrogenic and mammary tumor inhibiting properties.
    Schneider MR; Ball H; Schönenberger H
    J Med Chem; 1985 Dec; 28(12):1880-5. PubMed ID: 4068009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol estrogens of the 1,1,2-triphenylbut-1-ene type: relationship between structure, estradiol receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activities.
    Schneider MR; Ball H; Schiller CD
    J Med Chem; 1986 Aug; 29(8):1355-62. PubMed ID: 3016262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties.
    Schneider MR; von Angerer E; Schönenberger H; Michel RT; Fortmeyer HP
    J Med Chem; 1982 Sep; 25(9):1070-7. PubMed ID: 6813499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetoxy substituted 1,1,2-triphenylbut-1-enes: estrogenic, antiestrogenic and mammary tumor inhibiting activity.
    Schneider MR
    J Cancer Res Clin Oncol; 1986; 112(2):119-24. PubMed ID: 3771620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.
    Schneider MR
    J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorocarbamate-mustard-linked 1,1,2-triphenylbut-1-enes with a selective antitumor activity on mammary tumors containing estrogen receptors.
    Schneider MR; Schuderer ML
    J Cancer Res Clin Oncol; 1988; 114(6):583-7. PubMed ID: 3204105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-[4-(N,N-bis-beta-chloroethylcarbamoyloxy)-phenyl]-1,2-bis- (hydroxyphenyl)-but-1-enes: drugs specifically targeted against estrogen receptor positive mammary tumors.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1990 Apr; 323(4):215-9. PubMed ID: 2360864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic estrogens: anilin mustard linked 1,1,2-triphenylbut-1-enes with mammary tumor inhibiting activity.
    Schneider MR; Schuderer ML
    Arch Pharm (Weinheim); 1989 Jan; 322(1):59-62. PubMed ID: 2730288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
    Hartmann RW; Schwarz W; Heindl A; Schönenberger H
    J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS; Parker CJ; McCague R; Jordan VC
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity.
    von Angerer E; Erber S
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potential antiestrogens of the 1,2-diphenyl-1-pyridyl-but-1-ene type. 2. Biological testing].
    Schwarz W; Hartmann RW; Schönenberger H
    Arch Pharm (Weinheim); 1991 Apr; 324(4):231-4. PubMed ID: 1863201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Phenylindenes: development of a new mammary tumor inhibiting antiestrogen by combination of estrogenic side effect lowering structural elements.
    Schneider MR; Ball H
    J Med Chem; 1986 Jan; 29(1):75-9. PubMed ID: 3941415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of 5-acetoxy-2-(4-acetoxyphenyl)-1-ethyl-3-methylindole (D 16726) on estrogen-dependent mammary tumors.
    von Angerer E; Prekajac J; Berger M
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):531-7. PubMed ID: 3924626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
    von Angerer E; Strohmeier J
    J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes.
    Hartmann RW; Kranzfelder G; von Angerer E; Schönenberger H
    J Med Chem; 1980 Aug; 23(8):841-8. PubMed ID: 7401112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
    Hartmann RW; Heindl A; Schwarz W; Schönenberger H
    J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
    Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
    Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.
    Jordan VC; Koch R; Mittal S; Schneider MR
    Br J Pharmacol; 1986 Jan; 87(1):217-23. PubMed ID: 3955300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.